Aarey Drugs & Pharmaceuticals
76.91
-1.19(-1.52%)
Market Cap₹218.07 Cr
PE Ratio59.51
IndustryHealthcare
Company Performance:
1D-1.52%
1M-0.76%
6M+1.81%
1Y+23.27%
5Y+97.71%
View Company Insightsright
More news about Aarey Drugs & Pharmaceuticals
13Aug 25
Aarey Drugs & Pharmaceuticals Reports Q1 Results: Revenue Dips, Profit Rises
Aarey Drugs & Pharmaceuticals released its Q1 FY26 unaudited financial results, showing a 19.48% decrease in total income to Rs. 1,037.60 lakhs. Despite lower revenue, profit after tax increased by 10.81% to Rs. 13.73 lakhs. Basic EPS improved by 9.09% to Rs. 0.48. The company maintained profitability despite revenue decline, suggesting effective cost management. The results were approved by the Board of Directors and reviewed by auditors.
 no imag found
1 Year Returns:+23.27%
Industry Peers
Sun Pharmaceutical
1,922.00
(+0.63%)
Divis Laboratories
8,744.50
(+2.92%)
Torrent Pharmaceuticals
4,932.00
(+0.93%)
Cipla
1,422.00
(-1.11%)
Zydus Life Science
1,124.50
(+1.88%)
Laurus Labs
1,866.20
(+3.62%)
Dr Reddys Laboratories
1,193.50
(+0.29%)
Lupin
2,175.50
(-0.57%)
Mankind Pharma
2,365.00
(-0.40%)
Aurobindo Pharma
1,617.80
(+0.61%)